TP53 and neoplasm: However, we assembled the largest cohort of patients with LUADs in the LFS R337H context, describing the clinical characteristics, clinical outcomes, and tumor somatic molecular profile in more detail, in addition to formulating hypotheses for the role of TP53 R337H in the carcinogenesis of these tumors.